The authorised ANDA is a therapeutic equivalent of the reference-listed drug (RLD), Corlanor tablets, in the same 5 mg and ...

The combined cGMP inspection and pre-licensing inspection (PLI), which took place between July 15 and July 26, 2024, is the ...

Pharma player Granules India Limited on Friday said it has received an Establishment Inspection Report (EIR) from the US Food ...

The Food and Drug Administration first approved the injectable medication for treating diabetes in 2017; the agency approved a drug with a higher dose of the active ingredient in Ozempic, called ...

Cipla’s FDA-compliant facilities and its investments in US-based units place it in a strong position to weather potential ...

Opening higher at ₹575.95 apiece on the BSE, shares of Granules India Ltd. rose further to touch an intraday high of ₹590.

Granules India announced that it has received an establishment inspection report (EIR) from the U.S. Food and Drug Administration (USFDA) for its Unit V facility located at Jawaharlal Nehru Pharma ...

While the notice means a nationwide ban on Flying Horse Special Mix Curry Powder in school meals, some local authorities — ...

Ghosh makes visible the moral double standards prevalent in social discourses, especially regarding trading and profiting ...

Native Vote 2024. While former President Donald Trump has disavowed the Heritage Foundation’s  Project 2025, his fingerprints ...

The stock rose by 9.88% to reach a day high of Rs 1,557.45 on the Bombay Stock Exchange (BSE).  At 10:41 am, shares of Cipla ...

Novo Nordisk disclosed it knows of 10 deaths and 100 hospitalizations from people taking compounded copies of its weight loss ...